High Drug Load Spray Dried Hollow Starch Microparticles for Pharmaceuticals, Functional Foods and Wellness Products


High drug load, high stability, high compatibility immediate-release, extended release or tailored delayed release microparticles for targeted gastrointestinal delivery.

Value Drivers: First in Human Studies.

Altus patented IND-enabling MicroSpheres+ technology is designed for the rapid cost-effective advance of new drugs from laboratory to clinic. Large batches or very small, the multi-particulate MicroSpheres+ platform provides simple solutions for early Ph I entry and simple Phase II dose-ranging for oral and intranasal routes of administration.

Lab to Clinic

Altus can also manage your First in Human studies through its cost-effective Quebec network of early phase CRO.

Patent Protection:

Formulations employing MicroSpheres+ technology fall under Altus Patent Umbrella providing benefits for molecules lacking in-market protection.